[ad_1]
The Paraguayan government announced on Monday the signing of a pre-contract to purchase one million doses of the Pfizer-BionTech vaccine. In this way, he will join the exclusive group of 10 Latin American countries that periodically receive shipments of serum from the American pharmaceutical company with which Argentina has never reached an agreement.
The possibility of testing the Pfizer vaccine in Argentina on the left supposedly in a good position in the country to be able to access a quantity of doses when they are available. But in the middle stood up short circuits who delayed the negotiation.
“This is very good news for Paraguay”, said the Paraguayan Minister of Health, Julio Borba, after meeting the president Mario abdo.
// Alberto Fernández gave a new explanation on why the negotiation with Pfizer was frustrated
It is not known when the first doses of Pfizer will arrive in Paraguay, which has immunized its population with Sputnik V, Sinopharm and AstraZéneca sera (in the latter case via the COVAX mechanism managed by the World Health Organization).
The minister said that initially the agreement provided for the acquisition of one million doses, although this amount may be increased in the future. The final contract would be signed in the first days of June, said Borba, quoted by the Asuncion newspaper. The nation.
Since the start of the pandemic, Paraguay has exceeded 322,000 infections and 8,360 deaths with a complex epidemiological situation and a health system on the verge of collapse.
Which countries have agreed with Pfizer
With the signing of the new contract, Paraguay It will thus join the group of Latin American countries which have already signed purchase contracts for Pfizer vaccines.
Mexico walks at the head of this group of nations with more than 11 million sera from the American pharmaceutical company received in different batches. The last shipment was 114,660 doses received on the 20th of this month. In addition, he anticipates the arrival of more shipments in the short term.
// Coronavirus in Spain: those under 60 vaccinated with AstraZéneca will receive a second dose of Pfizer
Peru It is another of the countries that has signed an agreement with Pfizer for 20 million doses and weekly deliveries. On May 20, he received a batch of 395,000 vaccines. So far, the Peruvian government has accumulated 3,241,000 sera through direct laboratory purchases, plus 117,000 additional doses under the COVAX program.
Too Colombia receives sera from this laboratory. It was not until May that the Colombian government predicted the arrival of a total of 2.1 million doses. This Monday, the country received 546,390 doses of Pfizer vaccine by COVAX.
Chile, in turn, he has received an average of 200,000 weekly doses since last March. The government of Sebastian piñera signed a contract for the total supply of 10 million sera, of which around 3 million have already been delivered.
And there’s more: Uruguay It also receives weekly vaccine deliveries from the North American pharmaceutical company. By the end of May, half a million doses will have been received.
Meanwhile, Brazil announced the signing of a second agreement for other 100 million doses from Pfizer, which would start arriving next September. The first agreement was signed in March. This month a total of two million units will arrive.
// Pan American Highway collapsed due to new restrictions and with accesses closed, transit turned into chaos
Also in Central America
Not only several South American countries have entered into agreements with Pfizer. In addition, three Central American countries are already receiving vaccines from the US laboratory.
Costa RicaFor example, he has already received 19 shipments of doses this year. The Savior also vaccinated its population with Pfizer units, although through the COVAX mechanism, just like Panama.
In addition, the Dominican Republic announced on Tuesday that it would buy two million more vaccines from Pfizer.
// New restrictions: Government is already debating extending strict quarantine after May 30
What the Argentine government said
Argentina did not make a deal with Pfizer, despite the country actively participating in phase 3 clinical trials. Initially, the government attributed this situation to “unacceptable conditions” imposed by the laboratory.
However, in a recent interview with CNN en Español, President Alberto Fernández said he was under the impression that “the United States has resolved to preserve its vaccines and Pfizer said, “I no longer sign contracts.”
But at the end of April, we learned that Pfizer offered the Alberto Fernández government an early vaccine allocation, probably 13 million doses, as part of the first negotiations with the US laboratory last July. The information can be found in an exclusive document revealed in the program “W: See and Rever»Led by the journalist Nicolas winazki at TN.
.
[ad_2]
Source link